Bristol Myers Squibb CEO to retire in November

Bristol Myers Squibb’s CEO plans to retire Nov. 1, and the drugmaker promoted two C-suite leaders effective immediately, according to an April 26 news release. 

Advertisement

With Giovanni Caforio, MD, retiring in a few months, Chief Commercialization Officer Christopher Boerner, PhD, was promoted to CFO and Adam Lenkowsky switched from head of major markets to Dr. Boerner’s role, the drug company said. 

Dr. Caforio will continue in his role as executive chair after Nov. 1 during a transition period for the board.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.